Deltex shares soar on new US contract news

The unnamed client is a university teaching hospital in Deltex's mid-Atlantic sales territory and the flagship site within a six hospital healthcare system. The

The hospital evaluated Deltex's oesophageal doppler monitoring (ODM) thoroughly in 150 patients undergoing either colorectal or urology surgery in November and December 2016.

In colorectal surgery ODM helped with 10% reduction in mean length of hospital stay and in urology surgery a 20% reduction.

“The...hospital has now started implementing ODM into its standard operating procedures for both colorectal and urological surgery,” Deltex said, adding that clinicians expect this to lead to use of 40 to 50 probes a month.

The system planned to introduce ODM into its two largest hospitals in the second quarter of 2018 and the remaining three by the final quarter of 2018 by which time the flagship hospital expects to have started to roll ODM usage out into other surgical disciplines, Deltex said.

Chief executive Ewan Phillips said successful implementation through the hospital and wider system would help drive overall US sales growth as well as providing an additional highly rated reference account.

"The results from the hospital's evaluation validate the value our ODM technology offers even in those hospitals that have the very best patient outcomes. It is noteworthy that this US hospital was able to use ODM to improve its patients' recoveries even though its starting points for lengths of stay for these types of surgery were already around half the NHS England average," he said.